Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for lower urinary tract symptoms after TURBt and BCG in high-risk non-muscle-invasive bladder cancer
ChiCTR2000040823Phase 4Completed
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mirabegron in Micturition disorder (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Overactive Bladder Symptom Score, Pollakiuria and 4 more. Started Aug 2017; status: completed.
02
Drugs
mirabegron
03
Conditions
Micturition disorder
Beyond the preview
Go deeper on ChiCTR2000040823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040823.